in my experience I noted that some hospitals demand to include in the report of a imaging-guided breast biopsy procedure the BI-RADS of the biopsy itself.
For instance, if I perform a US-guided biopsy to a suspicious nodule which may be reported by a colleague as US-BIRADS: 4, I need to include in the biopsy’s report a new BIRADS.
However, I noted some confusion. In these hospitals, some radiologists report the biopsy-BIRADS on the basis of their opinion of such nodule during the biopsy while other radiologists report the biopsy-BIRADS on the basis of the hystopathological results of the biopsy.
What do you think about it?
Which approach do you think is more appropriate?
Many thanks for your help!